Friday, May 13, 2016

Mylan To Acquire Renaissance' Specialty & Generics Business For $950 Mln In Cash

Mylan N.V. (MYL) Friday said it agreed to acquire the non-sterile, topicals-focused specialty and generics business of privately held Renaissance Acquisition Holdings, LLC for $950 million in cash. The deal includes additional contingent payments of up to $50 million, subject to customary adjustments.

from RTT - Earnings http://ift.tt/1OrIaNw
via IFTTT

No comments:

Post a Comment